a) Inflammatory myopathies
First autor |
Patients |
Age |
Gender |
Rheumatic disease |
Anti-TNF administered |
AD triggered |
|---|---|---|---|---|---|---|
Urata |
1 |
52 |
F |
RA |
Infliximab |
Polymyositis |
May |
1 |
44 |
F |
RA |
Etanercept |
Dermatomyositis |
Flendrie |
1 |
52 |
F |
RA |
Lenercept |
Dermatomyositis |
Musial |
1 |
52 |
F |
RA |
Infliximab |
Polymyositis |
b) Sclerosis/sclerederma
First autor |
Patients |
Age |
Gender |
Rheumatic disease |
Anti-TNF administered |
AD triggered |
|---|---|---|---|---|---|---|
Ranganathan |
1 |
52 |
F |
RA |
Infliximab |
Scleredema |
c) Autoimmune hepatitis
First autor |
Patients |
Age |
Gender |
Rheumatic disease |
Anti-TNF administered |
AD triggered |
|---|---|---|---|---|---|---|
Germano |
1 |
53 |
F |
PsA |
Infliximab |
Autoimmune hepatitis |
Marques |
1 |
34 |
F |
UC |
Infliximab |
Autoimmune hepatitis |
Ozorio |
1 |
56 |
F |
AS |
Infliximab |
Autoimmune hepatitis |
Tobon |
1 |
39 |
F |
RA |
Infliximab |
Autoimmune hepatitis |
Tobon |
1 |
52 |
F |
RA |
Infliximab |
Autoimmune hepatitis |
Menghini |
1 |
44 |
F |
CD |
Infliximab |
Cholestatic hepatitis |
Saleem |
1 |
36 |
F |
RA |
Infliximab |
Autoimmune hepatitis |
d) Inflammatory eye diseases
First author |
Patients |
Age |
Gender |
Rheumatic disease |
Anti-TNF administered |
AD triggered |
|---|---|---|---|---|---|---|
Reddy |
1 |
44 |
F |
AS |
Etanercept |
Anterior uveitis |
Kaipiainen |
1 |
31 |
F |
JIA |
Etanercept |
Anterior uveitis |
Smith |
1 |
46 |
M |
PsA |
Etanercept |
Uveitis |
Smith |
1 |
51 |
F |
RA |
Etanercept |
Anterior uveitis |
Tiliakos |
1 |
58 |
F |
RA |
Etanercept |
Anterior uveitis |
Tiliakos |
1 |
48 |
F |
RA |
Etanercept |
Scleritis |
Smith |
1 |
61 |
F |
RA |
Etanercept |
Scleritis |
Smith |
1 |
56 |
M |
RA |
Etanercept |
Scleritis |
Smith |
1 |
45 |
F |
RA |
Etanercept |
Scleritis |
Caramaschi |
1 |
42 |
F |
RA |
Etanercept |
Orbital myositis |
Taban |
1 |
52 |
F |
AS |
Etanercept |
Anterior uveitis |
Tran |
1 |
45 |
F |
PsA |
Infliximab |
Optic neuritis |
Agarwal |
1 |
65 |
F |
RA |
Infliximab |
Endogenous endophthalmitis |
Di Gangi |
1 |
48 |
F |
RA |
Infliximab |
Uveitis |